Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.
Jeremy Veenstra-VanderWeele
From this contributor
Why serotonin medications may yet help children with autism
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can't we tell if these medications work similarly in children with the condition?
Why serotonin medications may yet help children with autism
How to evaluate new medications for autism
There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.
How to evaluate new medications for autism
Explore more from The Transmitter
Remembering Avis H. Cohen, who bridged disciplines to decode lamprey locomotion
The founding director of the University of Maryland’s Neuroscience and Cognitive Science program brought neuroscience, math and engineering together.
Remembering Avis H. Cohen, who bridged disciplines to decode lamprey locomotion
The founding director of the University of Maryland’s Neuroscience and Cognitive Science program brought neuroscience, math and engineering together.
When autistic kids grow up, Chapter 4: How did things unfold?
Tempest McDonald sues Vanderbilt University Medical Center through the Equal Employment Opportunity Commission. Her published NIH paper finds allies.
When autistic kids grow up, Chapter 4: How did things unfold?
Tempest McDonald sues Vanderbilt University Medical Center through the Equal Employment Opportunity Commission. Her published NIH paper finds allies.
NeuroDev study maps previously unseen genetic variation in Africa
The project is helping to fill critical gaps in the genetic underpinnings of autism and other neurodevelopmental conditions.
NeuroDev study maps previously unseen genetic variation in Africa
The project is helping to fill critical gaps in the genetic underpinnings of autism and other neurodevelopmental conditions.